Anandita Vyakarnam focuses her practice on intellectual property matters. She is admitted to the Patent Bar and brings two decades of experience to her practice that includes complex patent litigation, patent counseling and opinions, IP due diligence, licensing, prosecution and post-grant patent review.
Anandita has significant expertise in patent litigations concerning pharmaceutical drug products and Abbreviated New Drug Applications. She has served as trial counsel in multiple litigations and has earned successful results for clients at the claim construction, trial and appellate levels. She has represented major pharmaceutical corporations in Hatch-Waxman litigations involving drugs for treating cancer, HIV, type-2 diabetes, high cholesterol, heartburn and Alzheimer’s disease, among others. Outside of the Hatch-Waxman space, she has litigated cases and advised clients in technology areas including chemical, medical devices, biotechnology, cosmetics, digital marketing technology, medical diagnostics, consumer products and mechanical devices.
In addition to her litigation practice, Anandita counsels clients on the drug approval process under the Hatch-Waxman Act including developing strategies for marketing drug products, designing around patents, and evaluating competitive patents. She has also counseled clients in evaluating intellectual property in the context of mergers and acquisitions and other corporate transactions, evaluating confidentiality, licensing, settlement and noncompetition agreements, developing domestic and international patent prosecution portfolios and post-grant patent practice before the US Patent and Trademark Office. Anandita’s scientific background and experience with litigation, patent prosecution and corporate transactions enables her to help clients develop strategies that keep their business objectives at the forefront.
Anandita has a Ph.D. in biochemistry and molecular biology. She completed postdoctoral fellowship in oncology with a focus on identification of genetic alterations that drive tumorigenesis.
State of New York
State of New Jersey
United States Court of Appeals for the Federal Circuit
United States District Courts for the District of New Jersey, Southern District of New York and Eastern District of New York
United States Patent and Trademark Office
American Bar Association, Member
American Intellectual Property Bar Association, Member